261 related articles for article (PubMed ID: 28548090)
1. Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration.
Jayatilaka H; Tyle P; Chen JJ; Kwak M; Ju J; Kim HJ; Lee JSH; Wu PH; Gilkes DM; Fan R; Wirtz D
Nat Commun; 2017 May; 8():15584. PubMed ID: 28548090
[TBL] [Abstract][Full Text] [Related]
2. ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
Yun MR; Choi HM; Kang HN; Lee Y; Joo HS; Kim DH; Kim HR; Hong MH; Yoon SO; Cho BC
Oncogene; 2018 Jan; 37(3):377-388. PubMed ID: 28945228
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
Ko HS; Kim JS; Cho SM; Lee HJ; Ahn KS; Kim SH; Lee EO
Bioorg Med Chem Lett; 2014 Feb; 24(4):1176-9. PubMed ID: 24440300
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer.
Yokotsuka M; Iwaya K; Saito T; Pandiella A; Tsuboi R; Kohno N; Matsubara O; Mukai K
Breast Cancer Res Treat; 2011 Apr; 126(2):311-8. PubMed ID: 20419393
[TBL] [Abstract][Full Text] [Related]
6. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells-derived IL-6 promotes invasion and metastasis of oral squamous cell carcinoma via JAK-STAT3 signalling.
Liu C; Zhou J; Zhang S; Fu J; Li Y; Hao Y; Yuan J; Tang F; Ge W; He H; Chen Q
Oral Dis; 2024 May; 30(4):2097-2109. PubMed ID: 37249062
[TBL] [Abstract][Full Text] [Related]
9. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
[TBL] [Abstract][Full Text] [Related]
10. IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.
Gross AC; Cam H; Phelps DA; Saraf AJ; Bid HK; Cam M; London CA; Winget SA; Arnold MA; Brandolini L; Mo X; Hinckley JM; Houghton PJ; Roberts RD
JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135299
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.
O'Keefe RA; Bhola NE; Lee DS; Johnson DE; Grandis JR
PLoS One; 2020; 15(1):e0227261. PubMed ID: 31914141
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
Wakabayashi H; Hamaguchi T; Nagao N; Kato S; Iino T; Nakamura T; Sudo A
Breast Cancer; 2018 Sep; 25(5):566-574. PubMed ID: 29557068
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts induce an aggressive phenotypic shift in non-malignant breast epithelial cells via interleukin-8 and S100A8.
Lim H; Koh M; Jin H; Bae M; Lee SY; Kim KM; Jung J; Kim HJ; Park SY; Kim HS; Moon WK; Hwang S; Cho NH; Moon A
J Cell Physiol; 2021 Oct; 236(10):7014-7032. PubMed ID: 33748944
[TBL] [Abstract][Full Text] [Related]
14. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma.
Wu J; Gao FX; Wang C; Qin M; Han F; Xu T; Hu Z; Long Y; He XM; Deng X; Ren DL; Dai TY
J Exp Clin Cancer Res; 2019 Jul; 38(1):321. PubMed ID: 31324197
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.
Sun W; Liu DB; Li WW; Zhang LL; Long GX; Wang JF; Mei Q; Hu GQ
Int J Oncol; 2014 May; 44(5):1551-60. PubMed ID: 24603891
[TBL] [Abstract][Full Text] [Related]
16. Overcoming sunitinib resistance with tocilizumab in renal cell carcinoma: Discordance between in vitro and in vivo effects.
Kamli H; Owens EP; Vesey DA; Prasanna R; Li L; Gobe GC; Morais C
Biochem Biophys Res Commun; 2022 Jan; 586():42-48. PubMed ID: 34826699
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.
Santer FR; Malinowska K; Culig Z; Cavarretta IT
Endocr Relat Cancer; 2010 Mar; 17(1):241-53. PubMed ID: 19966016
[TBL] [Abstract][Full Text] [Related]
18. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
